Baum M
Am J Physiol. 1987 Feb;252(2 Pt 2):F338-45. doi: 10.1152/ajprenal.1987.252.2.F338.
The present in vitro microperfusion study examined whether active NaCl transport in the proximal convoluted tubule (PCT) occurs via parallel Na+-H+ and Cl(-)-HCO3-(OH-) exchangers. PCT were perfused with a high-chloride, low-bicarbonate solution simulating late proximal tubular fluid, and were bathed in a similar solution containing 6 g/dl albumin. In this setting the driving forces responsible for passive NaCl transport are eliminated. Addition of 0.1 or 0.5 mM luminal 4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid (SITS), 0.5 mM luminal 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS), or 0.1 mM bath ethoxyzolamide, a lipophilic carbonic anhydrase inhibitor, resulted in an approximately 50% reduction in volume absorption. Inhibition of the Na+-H+ antiporter with 1.0 mM luminal amiloride inhibited volume absorption by 50%. The transepithelial potential difference (PD) was not significantly different from zero, consistent with an electroneutral mechanism for active NaCl transport. The effect of a Cl(-)-HCO3-(OH-) exchanger on acidification was examined in PCT perfused with an ultrafiltrate-like solution and bathed in a serumlike albumin solution. Addition of 0.5 mM DIDS did not significantly decrease volume absorption, demonstrating that luminal DIDS did not result in a nonspecific decrease in solute transport. Luminal DIDS significantly stimulated bicarbonate absorption, consistent with a Na+-H+ antiporter running in parallel with a Cl(-)-HCO3-(OH-) antiporter, which exchanges luminal Cl- for cellular HCO3- (or OH-). In conclusion, these data are consistent with parallel Na+-H+ and Cl(-)-HCO3-(OH-) antiporters mediating neutral active NaCl transport in the PCT.
目前的体外微灌注研究探讨了近端曲管(PCT)中活性氯化钠转运是否通过并行的Na⁺-H⁺和Cl⁻-HCO₃⁻(OH⁻)交换体进行。用模拟近端肾小管晚期液体的高氯、低碳酸氢盐溶液灌注PCT,并将其置于含有6 g/dl白蛋白的类似溶液中。在此环境下,负责被动氯化钠转运的驱动力被消除。添加0.1或0.5 mM管腔4-乙酰氨基-4'-异硫氰酸基芪-2,2'-二磺酸(SITS)、0.5 mM管腔4,4'-二异硫氰酸基芪-2,2'-二磺酸(DIDS)或0.1 mM浴槽乙氧唑胺(一种亲脂性碳酸酐酶抑制剂),导致体积吸收减少约50%。用1.0 mM管腔氨氯吡咪抑制Na⁺-H⁺反向转运体可使体积吸收减少50%。跨上皮电位差(PD)与零无显著差异,这与活性氯化钠转运的电中性机制一致。在灌注类似超滤液的溶液并置于类似血清白蛋白溶液中的PCT中,研究了Cl⁻-HCO₃⁻(OH⁻)交换体对酸化的影响。添加0.5 mM DIDS并未显著降低体积吸收,表明管腔DIDS不会导致溶质转运的非特异性降低。管腔DIDS显著刺激碳酸氢盐吸收,这与与Cl⁻-HCO₃⁻(OH⁻)反向转运体并行运行的Na⁺-H⁺反向转运体一致,后者将管腔Cl⁻与细胞内HCO₃⁻(或OH⁻)交换。总之,这些数据与并行的Na⁺-H⁺和Cl⁻-HCO₃⁻(OH⁻)反向转运体介导PCT中的中性活性氯化钠转运一致。